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The osteomalacia in this patient was not due to malabsorption or renal disease. The dietary intake of vitamin D was assessed as being definitely above 70 IU/day, which is regarded by Dent and Smith (1969) 
Introduction
The major fraction of organic iodine in the circulation is in the form of L-thyroxine (T4). Although significant amounts of 3, 5, 3'-triiodo-L-thyronine (T-3) are present (Gross and Pitt-Rivers, 1952) (Sterling et al., 1969) which are much more precise but which are very time consuming. The accuracy of these techniques has also been questioned on the basis of the conversion of TX to T-3 during the assay procedure (Larsen, 1971a) . The production of specific antibodies to T-3 was first described by Brown et al. (1970a) , and more recently techniques for the measurement of T-3 in unextracted serum have been reported (Chopra et al., 1971; Lieblich and Utiger, 1971; Mitsuma et al., 1971; Larsen, 1972a) .
Methods
Preparation of Antiserum.-Specific T-3 antisera were raised by the serial injection of T-3-methyl ester hydrochloride conjugated to bovine serum albumin (Hesch and Huefner, 1972) . Antisera were raised in each of the three rabbits immunized.
Assay.-'l-I-labelled T-3 (80-125 mCi/mg) was obtained from Byk-Mallinckrodt, St. Louis, U.S.A., or from the Radiochemical Centre, Amersham (30-50 mCi/mg). Human serum free of T-3 was prepared by mixing normal serum with Amberlite resin CG400, type 11, 200 mesh (Rhom and Haas Co.), 1 ml serum to 100 mg resin for 30 minutes after warming to 40°C. Standard solutions of T-3 were prepared with T-3 obtained from various commercial sources-for example, Sigma Chemical Co., St. Louis, and Georg Henning, Chem. Pharmn. Werk, G.m.b.H., Berlin-and these were shown by experiment to give identical standard curves. The assay procedure carried out in the two centres was as fellows.
Solutions.-Buffer: sodium phosphate 0-05 mol/l. pH 7-6 with human serum albumin. Standard solutions: ranging from 0-500 pg T-3/assay tube. Blocking agent: merthiolate 1: 1,000 in tris/ HC1 0 05 mol/l. pH 9-0 (Gottingen); sodium salicylate 5 mg/0-1 ml 0 05 mol/l. sodium phosphate (Newcastle). Tracer solution: 15-30 pg 125I-labelled T-3 (Gottingen); 100 pg 1251-labelled T-3 (Newcastle). Antibody solution: rabbit anti-T-3 serum diluted in 0.9% sodium chloride. Dextran/charcoal: 0-15 g dextran T70 to 1 g Norit A in 0.05 mol/l. sodium phosphate buffer (100 ml). Specificity.-The cross-reactivity with T-4 was found to be less than 0-1%. Thus the presence of a normal concentration of TA in human serum (about 80 by 10-9 g/ml) would lead to an artefactual rise of serum T-3 concentration of less than 0-08 by 10-9 g/ml. There was no measurable cross-reactivity with monoiodotyrosine or diiodotyrosine but there was 30% cross-reactivity with triiodothyracetic acid.
Assay Procedure Gottingen 0-02-0-1 ml standard or unknown serum.
0-05 ml l25I-labelled T-3. 0-05 ml antiserum (final dilution) 1/20,000. 0 5 ml buffer with merthiolate. Newcastle 0-5 ml buffer (with or without standard).
0-1 ml T-3 free or unknown serum.
0.1 ml sodium salicylate.
0-1 ml 125I-labelled T-3.-0-1 ml antiserum (final dilution) 1/ 12,600. Incubate overnight at 4°C with appropriate blanks. Add 0-5 ml dextran/charcoal to each. Centrifuge after exactly five minutes. Decant supernatant and count the charcoal residue in an automatic well scintillation counter.
Results
Standard Curve.-The addition of increasing quantities of T-3 to the reaction mixture leads to progressive decreases in the proportion of 1251I-labelled T-3 bound to the antiserum ( fig. 1) . At the antiserum concentration used it was found that 60-75% of the labelled T-3 was bound. The addition of stable T-3 to une*tracted serum and the measurement of serial dilutions of hyperthyroid sera produce displacement curves which can be superimposed on the standard curve. It was found that equilibration was complete within 2-5 hours
The serum T-3 concentration was estimated in 54 adult euthyroid subjects in Newcastle ( fig. 2 ). These were members of hospital staff, patients who were not suspected of having thyroid disease, and patients with suspected thyroid disease in whom all measurements of thyroid function were normal and who responded normally to intravenous thyrotrophin-releasing hormone according to the criteria of Ormston et al. (1971) . The mean serum T-3 concentration in these subjects was 1-26 ng/ml (S.D. ± 0-23 ng/ml) observed range 0-76-1-67 ng/ml. The total serum T-3 concentration was measured in 130 euthyroid subjects in Gottingen who were selected on the same basis. The mean serum T-3 concentration in these subjects was 1-20 ng/ml (S.D. ± 030 ng/ml) and the observed range was 0-80-1-50 ng/ml.
SERUM T-3 CONCENTRATION IN HYPOTHYROIDISM
The serum T-3 concentration was estimated in 39 subjects with overt hypothyroidism in Newcastle (Evered and Hall, 1972) . The mean value in these subjects was 0-48 ng/ml, observed range from 0-1-07 ng/ml, and it will be observed that there was some overlap with the normal group ( fig. 2) cedures. The production of specific antibodies to T-3 was first described by Brown et al. (1970a) and they developed a satisfactory assay system on extracted serum (Brown et al., 1970b (Brown et al., , 1971 . This system first showed that serum T-3 concentrations measured by immunological techniques appeared to be substantially lower than those reported by Sterling et al. (1969) . The specificity and sensitivity of this assay appear to be similar to those reported here. The range of values reported in normal subjects (075-1-6 ng/ml) is similar to the range observed in the present study (Brown et al., 1971 (sodium salicylate and merthiolate) which inhibit the binding of T-3 by thyroxine-binding globulin and also by thyroxinebinding prealbumin (Larsen, 1971b; Larsen, 1972b) . The concentration of salicylate used in this assay is sufficient to com-D-9O ng/ml and again some pletely inhibit the binding of T-3 by the serum proteins. It vas noted.
has thus been possible to develop a rapid, sensitive, and precise assay system for the measurement of T-3 in unextracted serum. Other workers have used diphenylhydantoin (Lieblich   'ERTHYROIDISM and Utiger, 1971), tetrachlorothyronine (Mitsuma et al., 1971) , or thyroxine (Chopra et al., 1971) to block the binding of T-3 ;estimated in 47 subjects by the serum proteins. The inhibition of T-3 binding by the iemical evidence of hyperserum proteins has been described in detail by Huefner and ranged from 1-77 to 11-88 Hesch (1973) .
the normal group and only Full details of the characteristics of the antisera used have md to have a serum T-3 also been reported (Hesch and Huefner 1972) . The present nl ( fig. 2 ). Rather higher antisera appear to compare very favourably with assays re--hyroid subjects studied in ported by other workers (Chopra et al., 1971 ; Mitsuma iged from 3 0 to 30 ng/ml.
et Larsen, 1972a) in that incubation periods are much shorter. The sensitivity of these assays appear to be similar to those reported by Missuma et al. (1971) and Lar-4TRATIONS sen (1972a) . The sensitivity of the assay described by Chopra (1971) appears to be very low in that the detection threshold ation between serum T-3 is as high as 1 ng/ml and thus this assay is unable to disconcentration (Thyopac4, tinguish reliably between normal and hypothyroid concernEstimation of the total trations of T-3.
The mean serum T-3 concentration in normal subjects is found to be 1-26 ng/ml (S.D. ± 0-23 ng/ml) in Newcastle and a O 1 20 ng/ml (S.D. ± 030 ng/ml) in G6ttingen using unextracted serum. The values are similar to those reported by Mitsuma et al. (1971) (1-38 ± 0-23 ng/ml) and by Larsen (1972a) o (1-10 ± 0-25 ng/ml) and rather lower than the mean value of 1 50 ng/ml reported by Lieblich and Utiger (1971 be accounted for by the conversion of T-4 to T-3 during the S.E-0.99109 assay procedure (Larsen, 1971a) . The serum T-3 concentrations observed in hypothyroidism are essentially similar to those reported by other workersthe mean value of 048 ng/ml being slightly higher than that noted by Larsen (1972a) (Evered et al., 1973) . The estimation of serum T-3 concentration appears to discriminate well between nonnal subjects and those with hyperthyroidism in all series and the range of T-3 concentrations appears to be similar in all the groups studied by all workers with mean values between 4-2 and 5 2 ng/ml. Subjects with minor degrees of hyperthyroidism, however, appear to have been excluded in the preliminary studies of serum T-3 concentrations reported. The discriminant value of this estimation in the diagnosis of hyperthyroidism remains to be definitely established. Raised serum T-3 concentrations have also been observed in other clinical situations which will be described elsewhere.
There is the generally expected correlation between serum TX and T-3 concentrations, and the relation between the concentrations of the two thyroid hormones in the serum is very similar to that reported by Larsen (1972a) . The only general deviation from this correlation is seen in the subjects with T-3 thyrotoxicosis, and also in some other clinical states. 
